Shenzhen YHLO Biotech Co Ltd
SSE:688575
Income Statement
Earnings Waterfall
Shenzhen YHLO Biotech Co Ltd
Revenue
|
2.4B
CNY
|
Cost of Revenue
|
-1.2B
CNY
|
Gross Profit
|
1.2B
CNY
|
Operating Expenses
|
-840.9m
CNY
|
Operating Income
|
355.1m
CNY
|
Other Expenses
|
69.1m
CNY
|
Net Income
|
424.2m
CNY
|
Income Statement
Shenzhen YHLO Biotech Co Ltd
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
999
N/A
|
1 108
+11%
|
1 118
+1%
|
1 147
+3%
|
1 178
+3%
|
2 312
+96%
|
2 967
+28%
|
3 450
+16%
|
3 981
+15%
|
3 271
-18%
|
2 719
-17%
|
2 397
-12%
|
|
Gross Profit | |||||||||||||
Cost of Revenue |
(410)
|
(450)
|
(478)
|
(480)
|
(524)
|
(908)
|
(1 314)
|
(1 533)
|
(1 929)
|
(1 744)
|
(1 371)
|
(1 201)
|
|
Gross Profit |
589
N/A
|
658
+12%
|
640
-3%
|
667
+4%
|
654
-2%
|
1 405
+115%
|
1 653
+18%
|
1 917
+16%
|
2 052
+7%
|
1 527
-26%
|
1 347
-12%
|
1 196
-11%
|
|
Operating Income | |||||||||||||
Operating Expenses |
(326)
|
(355)
|
(400)
|
(412)
|
(422)
|
(624)
|
(835)
|
(903)
|
(911)
|
(893)
|
(766)
|
(841)
|
|
Selling, General & Administrative |
(210)
|
(251)
|
(277)
|
(291)
|
(258)
|
(468)
|
(611)
|
(671)
|
(588)
|
(554)
|
(459)
|
(473)
|
|
Research & Development |
(98)
|
(117)
|
(128)
|
(130)
|
(119)
|
(156)
|
(194)
|
(209)
|
(222)
|
(245)
|
(249)
|
(277)
|
|
Depreciation & Amortization |
(46)
|
0
|
0
|
0
|
(67)
|
0
|
0
|
0
|
(119)
|
0
|
0
|
0
|
|
Other Operating Expenses |
28
|
14
|
5
|
10
|
22
|
(0)
|
(29)
|
(23)
|
20
|
(93)
|
(58)
|
(91)
|
|
Operating Income |
263
N/A
|
303
+15%
|
240
-21%
|
255
+6%
|
232
-9%
|
780
+237%
|
818
+5%
|
1 013
+24%
|
1 141
+13%
|
634
-44%
|
582
-8%
|
355
-39%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
(16)
|
(15)
|
(15)
|
(10)
|
(6)
|
(5)
|
74
|
68
|
72
|
60
|
1
|
101
|
|
Non-Reccuring Items |
(1)
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(12)
|
0
|
(0)
|
(0)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
|
Total Other Income |
(4)
|
(1)
|
0
|
1
|
1
|
0
|
(3)
|
(7)
|
(12)
|
(15)
|
(12)
|
(12)
|
|
Pre-Tax Income |
242
N/A
|
287
+19%
|
225
-22%
|
246
+9%
|
228
-7%
|
775
+240%
|
889
+15%
|
1 074
+21%
|
1 186
+10%
|
679
-43%
|
571
-16%
|
443
-22%
|
|
Net Income | |||||||||||||
Tax Provision |
(34)
|
(41)
|
(26)
|
(28)
|
(24)
|
(100)
|
(120)
|
(131)
|
(165)
|
(98)
|
(92)
|
(75)
|
|
Income from Continuing Operations |
208
|
246
|
200
|
217
|
204
|
675
|
769
|
943
|
1 022
|
581
|
478
|
368
|
|
Income to Minority Interest |
3
|
3
|
(1)
|
(1)
|
1
|
3
|
13
|
(20)
|
(9)
|
1
|
10
|
56
|
|
Net Income (Common) |
211
N/A
|
249
+18%
|
198
-20%
|
216
+9%
|
205
-5%
|
678
+231%
|
782
+15%
|
923
+18%
|
1 012
+10%
|
582
-42%
|
488
-16%
|
424
-13%
|
|
EPS (Diluted) |
0.58
N/A
|
0.68
+17%
|
0.34
-50%
|
0.38
+12%
|
0.36
-5%
|
1.2
+233%
|
1.38
+15%
|
1.63
+18%
|
1.79
+10%
|
1.03
-42%
|
0.86
-17%
|
0.74
-14%
|